Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Aurobindo Pharma is a leading Indian pharmaceutical company specializing in the development, manufacturing, and global distribution of high-quality generics, APIs, and specialty pharmaceuticals. The company provides essential medicines across diverse therapeutic areas, contributing significantly to global healthcare access and delivery.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Aurobindo Pharma is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Aurobindo Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 17.86 INR.
Aurobindo Pharma has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.